UCSF Memory and Aging Center

Key facts

• Professor of Neurology, UCSF Memory and Aging Center; research interest in assessment, management and treatment of rapidly progressive dementias including prion disease; helped establish the first inpatient RPD assessment program in the US; helped run the first US treatment study for CJD; directs the MAC Huntington disease center; NIH-funded project Predicting progression of human prion disease 2007 to 2020.
• The center describes Geschwind as leading its clinical research program in rapidly progressive dementia, with a referral page on the site.
• Geschwind's NIH grants include presymptomatic genetic prion disease tracking (2019 to May 2025) and prion progression prediction (2007 to 2020).
• The center also directs a Huntington disease center and an autoimmune encephalopathy clinic.
• Geschwind sits on the 2026 CJD Foundation genetic prion workshop.

Timeline

1. 2019NIH presymptomatic cohort grant starts.
2. 2025NIH presymptomatic cohort grant ends.
3. 2026CJD Foundation conference programme lists Geschwind.